QuidelOrtho Corporation Investor Presentation — January 2021

Document content

JPM Investor Presentation

January 13, 20212 Copyright © 2021 Quidel Corporation. All rights reserved.Forward -Looking Statements

This presentation contains forward -looking statements within the meaning of the federal securities laws that involve material ri sks, assumptions and uncertainties. Many possible events or factors could affect our future results and

performance, such that our actual results and performance may differ materially from those that may be described or implied i n the forward -looking statements. As such, no forward -looking statement can be guaranteed. Differences in actual

results and performance may arise as a result of a number of factors including, without limitation: the impact and duration o f the novel virus (COVID -19) global pandemic; funding and compliance risks relating to government contracts,

including our ability to meet key deliverables and milestones under our NIH RADx -ATP contract; our ability to accurately forecast demand for our products and products in development, including in new market segments; adverse changes in

competitive conditions, the reimbursement system currently in place and future changes to that system, changes in economic co nditions in our domestic and international markets, lower than anticipated market penetration of our products,

our reliance on sales of our influenza and COVID -19 diagnostic tests, fluctuations in our operating results resulting from the t iming of the onset, length and severity of cold and flu seasons, seasonality, government and media attention focused

on influenza and other respiratory or novel viruses and the related potential impact on humans from such viruses; our ability tomeet demand for our products; interruptions, delays or shortages in the supply of raw materials, equipment and

other components; the quantity of our product in our distributors’ inventory or distribution channels; changes in the buying patterns of our distributors; changes in the healthcare market and consolidation of our customer base; our